Why
SABIC is funding a new line at Cartagena with a decision window inside two quarters
Clustering the last scan…
Clustering the last scan…
Capital Moves · Peaked
SABIC is funding a new line at Cartagena with a decision window inside two quarters
SABIC's recent patent activity points at a bio-based substitution programme
SABIC faces an EU REACH restriction that puts two product lines out of compliance by 2027